1E Therapeutics Patents – Insights & Stats (Updated 2024)

1E Therapeutics has a total of 32 patents globally, out of which 2 have been granted. Of these 32 patents, more than 84% patents are active. United States of America is where 1E Therapeutics has filed the maximum number of patents, followed by Europe (EPO) and Australia. Parallelly, United States of America seems to be the main focused R&D centre and also Israel is the origin country of 1E Therapeutics.

1E Therapeutics was founded in the year 2020. 1E Therapeutics is an innovative drug development company specializing in RNA-targeting therapeutics. Using a proprietary drug design platform, they aim to revolutionize treatment options by creating cutting-edge therapies that address critical medical challenges.

Do read about some of the most popular patents of 1E Therapeutics which have been covered by us in this article and also you can find 1E Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over 1E Therapeutics patent portfolio.

How many patents does 1E Therapeutics have?

1E Therapeutics has a total of 32 patents globally. These patents belong to 6 unique patent families. Out of 32 patents, 27 patents are active.

How Many Patents did 1E Therapeutics File Every Year?

1E Therapeutics Patent FIling Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or Grant1E Therapeutics Applications Filed1E Therapeutics Patents Granted
202412
20234
202211
202116

How many 1E Therapeutics patents are Alive/Dead?

1E Therapeutics Patent Portfolio

 How Many Patents did 1E Therapeutics File in Different Countries?

1E Therapeutics Worldwide Patent Filing

Countries in which 1E Therapeutics Filed Patents

CountryPatents
United States of America5
Europe (EPO)5
Australia5
Israel5
Korea (South)5
Hong Kong (S.A.R.)1

Where are Research Centres of 1E Therapeutics Patents Located?

The Research Centre for all the 1E Therapeutics patents is the United States of America.

List of 1E Therapeutics Patents

1E TherapeuticsTitle
US11981896B2P21 Mrna Target Areas For Silencing
US11879140B2P21 Mrna Targeting Dnazymes
US20240076671A1P21 Mrna Targeting Dnazymes
EP4384620A1Dnazymes Targeting Cell Wall Synthesis Enzymes And Uses Thereof
EP4381073A1Guanine-Rich Deoxyribozymes, Compositions And Uses Thereof
WO2024105654A1Methods And Compositions Including Conjugated Dnazymes
AU2021411103A9P21 Mrna Target Areas For Silencing
AU2021416356A9P21 Mrna Targeting Dnazymes
HK40101784AP21 Mrna Target Areas For Silencing
IL310312ADnazymes Targeting Cell Wall Synthesis Enzymes And Uses Thereof
IL310313AGuanine-Rich Deoxyribozymes, Compositions And Uses Thereof
AU2022325553A1Dnazymes Targeting Cell Wall Synthesis Enzymes And Uses Thereof
AU2022322003A1Guanine-Rich Deoxyribozymes, Compositions And Uses Thereof
AU2021374966A9Catalytic Sequence Based Methods Of Treating Or Preventing Bacterial Infections
KR1020240045303ADnazyme Targeting Cell Wall Synthesis Enzyme And Its Uses
KR1020240042013AGuanine-Rich Deoxyribozyme, Compositions And Uses Thereof
US20230416750A1Catalytic Sequence Based Methods Of Treating Or Preventing Bacterial Infections
US20230265424A1Methods Of Treating And Preventing Bacterial Infections
EP4267741A2P21 Mrna Target Areas For Silencing
EP4267742A2P21 Mrna Targeting Dnazymes
EP4240856A2Catalytic Sequence Based Methods Of Treating Or Preventing Bacterial Infections
WO2023017501A1Dnazymes Targeting Cell Wall Synthesis Enzymes And Uses Thereof
WO2023012801A1Guanine-Rich Deoxyribozymes, Compositions And Uses Thereof
IL304068AP21 Mrna Targeting Dnazymes
IL304047AP21 Mrna Target Areas For Silencing
IL302594ACatalytic Sequence Based Methods Of Treating Or Preventing Bacterial Infections
KR1020230133859AP21 Mrna Targeting Dnazyme
KR1020230126725AP21 Mrna Target Site For Silencing
KR1020230107296AMethods For Treating Or Preventing Bacterial Infections Based On Catalytic Sequences
WO2022144883A3P21 Mrna Targeting Dnazymes
WO2022144882A3P21 Mrna Target Areas For Silencing
WO2022097157A3Catalytic Sequence Based Methods Of Treating Or Preventing Bacterial Infections

What are 1E Therapeutics key innovation segments?

What Technologies are Covered by 1E Therapeutics?

The chart below distributes patents filed by 1E Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where 1E Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has 1E Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by 1E Therapeutics?

Related Articles

Clobotics Patents – Insights & Stats (Updated 2024)

Clobotics has a total of 160 patents globally, out of which 81 have been granted. Of these 160 patents, more than 61% patents are active. China is where Clobotics has filed the maximum number of patents, followed by United States of America and Mexico. Parallelly, China seems to be the

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.